BMS Presents Encouraging Data from Phase 1 Breakfree-1 Study of CD19 NEX-T™ CAR T Cell Therapy in Three Chronic Autoimmune Diseases at ACR.
Results from pre-clinical studies demonstrate immunomodulatory activity of QEL-005 across multiple immune cell lineages involved in complex autoimmune inflammation, including B cells, T cells and ...
Retinal inner layer thinning detected by OCT offers a promising biomarker for monitoring multiple sclerosis progression.
It’s also worth noting that even if you have MS disability benefits through Social Security, you do not automatically receive ...
Among individuals with MS, the risk of serious infection was higher and the time to the first serious infection was shorter ...
Rocky Mountain MS Clinic’s John Foley, M.D., and Rebekah Foster, head of data at Nira Medical, describe harnessing the power ...
With ads everywhere for pro- or pre-biotic foods and supplements, most people are familiar with the gut microbiome—the ...
BioNxt Solutions Inc. (CSE:BNXT) (OTCQB:BNXTF) (FSE:BXT), a bioscience company developing next-generation drug delivery ...
New study shows oral microbiome imbalance and reduced salivary hypotaurine may contribute to neuroinflammation in relapsing-remitting MS.
A machine learning model may be a valid method of determining the risk for recurrence of MS among individuals who discontinue ...
The large-mass animal crossover bioequivalence study will commence in the next two to three weeks and will be carried out ...
ALS is more common in some parts of the U.S. than others and it has a very strong geographic association with MS, a new study ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results